Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Acthera Therapeutics's investors include IMD Startup Competition.
Acthera Therapeutics is headquartered in Basel, Switzerland.
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Acthera Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Acthera Therapeutics — Funding & Investors." VCBacked, December 12, 2022, https://www.vcbacked.co/company/acthera-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Acthera Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/acthera-therapeutics
{{cite web |title=Acthera Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/acthera-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated